Cannara Biotech LOVFF Stock
Cannara Biotech Price Chart
Cannara Biotech LOVFF Financial and Trading Overview
| Cannara Biotech stock price | 1.19 USD |
| Previous Close | 1.23 USD |
| Open | 1.25 USD |
| Bid | 1.19 USD x 430000 |
| Ask | 1.22 USD x 350000 |
| Day's Range | 1.25 - 1.25 USD |
| 52 Week Range | 0.81 - 1.47 USD |
| Volume | 5 USD |
| Avg. Volume | 7.05K USD |
| Market Cap | 123.48M USD |
| Beta (5Y Monthly) | 0.375 |
| PE Ratio (TTM) | 15.625 |
| EPS (TTM) | 0.08 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LOVFF Valuation Measures
| Enterprise Value | 129.88M USD |
| Trailing P/E | 15.625 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.092579 |
| Price/Book (mrq) | 1.4829918 |
| Enterprise Value/Revenue | 1.149 |
| Enterprise Value/EBITDA | 5.425 |
Trading Information
Cannara Biotech Stock Price History
| Beta (5Y Monthly) | 0.375 |
| 52-Week Change | 40.71% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 1.47 USD |
| 52 Week Low | 0.81 USD |
| 50-Day Moving Average | 1.3 USD |
| 200-Day Moving Average | 1.28 USD |
LOVFF Share Statistics
| Avg. Volume (3 month) | 7.05K USD |
| Avg. Daily Volume (10-Days) | 714 USD |
| Shares Outstanding | 98.78M |
| Float | 45.5M |
| Short Ratio | N/A |
| % Held by Insiders | 50.10% |
| % Held by Institutions | 0.25% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2025 |
| Most Recent Quarter (mrq) | February 28, 2026 |
| Next Fiscal Year End | August 31, 2026 |
Profitability
| Profit Margin | 8.98% |
| Operating Margin (ttm) | 12.40% |
| Gross Margin | 42.47% |
| EBITDA Margin | 21.18% |
Management Effectiveness
| Return on Assets (ttm) | 6.49% |
| Return on Equity (ttm) | 9.47% |
Income Statement
| Revenue (ttm) | 113.01M USD |
| Revenue Per Share (ttm) | 1.21 USD |
| Quarterly Revenue Growth (yoy) | 2.60% |
| Gross Profit (ttm) | 48M USD |
| EBITDA | 23.94M USD |
| Net Income Avi to Common (ttm) | 10.16M USD |
| Diluted EPS (ttm) | 0.08 |
| Quarterly Earnings Growth (yoy) | -49.79% |
Balance Sheet
| Total Cash (mrq) | 21.9M USD |
| Total Cash Per Share (mrq) | 0.22 USD |
| Total Debt (mrq) | 34.22M USD |
| Total Debt/Equity (mrq) | 28.47 USD |
| Current Ratio (mrq) | 3.06 |
| Book Value Per Share (mrq) | 0.8428907 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 27.64M USD |
| Levered Free Cash Flow (ttm) | 13.19M USD |
Profile of Cannara Biotech
| Country | United States |
| State | QC |
| City | Saint-Laurent |
| Address | 333 Decarie Blvd. |
| ZIP | H4N 3M9 |
| Phone | 514 543 4200 |
| Website | https://cannara.ca |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 452 |
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Q&A For Cannara Biotech Stock
What is a current LOVFF stock price?
Cannara Biotech LOVFF stock price today per share is 1.19 USD.
How to purchase Cannara Biotech stock?
You can buy LOVFF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cannara Biotech?
The stock symbol or ticker of Cannara Biotech is LOVFF.
Which industry does the Cannara Biotech company belong to?
The Cannara Biotech industry is Drug Manufacturers - Specialty & Generic.
How many shares does Cannara Biotech have in circulation?
The max supply of Cannara Biotech shares is 98.78M.
What is Cannara Biotech Price to Earnings Ratio (PE Ratio)?
Cannara Biotech PE Ratio is 14.81875000 now.
What was Cannara Biotech earnings per share over the trailing 12 months (TTM)?
Cannara Biotech EPS is 0.08 USD over the trailing 12 months.
Which sector does the Cannara Biotech company belong to?
The Cannara Biotech sector is Healthcare.